Helios Underwriting - Directorship Change
29/06/2023 15:46
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230629:nRSc4370Ea&default-theme=true
RNS Number : 4370E Helios Underwriting Plc 29 June 2023
29 June 2023
Helios Underwriting plc
("Helios" or the "Company")
Directorship Change
Helios, the investment vehicle which builds shareholder value through exposure
to Lloyd's, is pleased to announce Michael Wade's appointment as Chairman on
closure of the Annual General Meeting today. He succeeds Michael Cunningham
who has retired from the Company.
Michael Wade has had an extensive career at Lloyd's working across broking,
underwriting, capital markets and insurance linked securities. Michael formed
one of the first Lloyd's corporate capital vehicles in 1993, CLM Insurance
Fund plc, and later acted for UK pension funds via Rostrum Group investing in
listed Lloyd's firms. He has served on the Council and Committee of Lloyd's
and was formerly a senior adviser to the Cabinet Office. Currently, Michael is
also Non-Executive Chairman of Howden Tiger Capital Markets UK and a senior
advisor to Mitsui Sumitomo Insurance.
Michael Wade, Chairman of Helios, commented: "I am delighted to be joining
Helios as Chairman at this exciting juncture of the Company's journey and I
look forward to working closely with the team. Helios should continue to
benefit from London's strong trading environment with firm insurance rates and
opportunities for the Company to grow."
Martin Reith, Chief Executive Officer of Helios, commented: "I am thrilled to
welcome Michael to the Board and look forward to working with him in his role
as Chairman. Helios is well positioned to benefit from the current market
environment and Michael's extensive industry knowledge and experience will be
a huge asset to the Board. I would also like to thank Michael Cunningham for
his leadership and dedication to Helios over the past 16 years and wish him
well in the future."
AIM Rule 17
Regulatory disclosures in accordance with Rule 17 Schedule Two paragraph (g)
of the AIM Rules for Companies.
Michael John Wade, aged 69, holds or has held in the last 5 years the
following directorships and/or partnerships:
Current directorships / partnerships Former directorships / partnerships in the past 5 years
Tigerrisk Capital Markets & Advisory (UK) Limited Trexit Limited
Flood Secure Limited Neon Underwriting Limited
Lloyd's Index Ltd TAAGR LLP
London Market Tracker Ltd
Lloyd's Market Tracker Ltd
87 Vincent Square Limited
Michael currently holds 116,470 ordinary shares in Helios.
In addition, Michael Wade was a director of EUC Re Limited (EUC) at the time
it was put into a creditors' voluntary liquidation on 11 March 2005. EUC was
subsequently dissolved on 10 September 2014.
Save as disclosed above, there are no further disclosures to be made in
accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.
For further information, please contact:
Helios Underwriting plc
Martin Reith - Chief Executive Officer
+44 (0)7720 292 505
Nigel Hanbury - Executive Deputy Chairman +44 (0)7787 530 404
Arthur Manners - Chief Financial Officer +44 (0)7754
965 917
Numis (Nomad and Broker)
Giles Rolls / Charles Farquhar
+44 (0)20 7260 1000
Buchanan (PR)
Helen Tarbet / George Beale
+44 (0)20 7466 5111
About Helios
Helios provides a limited liability direct investment into the Lloyd's
insurance market and is quoted on the London Stock Exchange's AIM market
(ticker: HUW). Helios trades within the Lloyd's insurance market writing
approximately £297m of capacity for the 2023 account. The portfolio provides
a good spread of business being concentrated in property & casualty
insurance and reinsurance. For further information please visit www.huwplc.com
(http://www.huwplc.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAEALKNALADEFA